EJJ-20382-90627
5 vaccinations
3 coded responses
49 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 393 / MS
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Moderna
-
2021-02-22
Registered in v-safe
-
2021-02-22
Dose 2 — Moderna
-
2021-02-22
Survey response — day 0, dose 2MedDRA: Emergency care, Immediate post-injection reaction, Injection site discolouration, Pruritus, Skin discolouration — Feeling: Fair · Site: Pain, Redness, Itching · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Within 15 minutes of second dose today, arm began itching and there was noticeable discoloration approximately two inches to left and below injection site. · Healthcare visit (other): EMT was at drive through vaccination site. She observed arm, listened to chest with stethoscope, no elevated heart rate noted and lungs clear, and asked if I had ever had an allergic reaction before. No need for further medical treatment. Itching preceded dark discoloration of upper arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Report sent to call center — day 0, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Fatigue or tirednessAdult check-in
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site pain, Injection site pruritus — Feeling: Good · Site: Pain, RednessFree text: I did not sign up for vsafe after my initial dose. 10 days following initial dose, I had redness, itching and pain at injection site that resolved within approximately 2 days. Just wanted you to have that information for your records.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-03
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-05-25
- 2021-08-23
- 2021-08-24
-
2021-10-29
Dose 3 — Moderna
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
-
2022-04-29
Dose 4 — Moderna
-
2022-04-29
Survey response — day 0, dose 4MedDRA: No adverse event — Feeling: GoodFree text: None so far - received fourth vaccination at about 10:30 am todayMedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2022-05-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2022-05-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-05-04
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2022-05-05
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-05-27
- 2022-06-03
- 2022-06-10
- 2022-07-31
-
2022-09-10
Dose 5 — ModernaCo-administered: Flu
-
2022-09-11
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-12
- 2022-09-16
- 2022-09-17
- 2022-09-24
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-12-12
- 2023-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Moderna | |
| 2 | 2021-02-22 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-04-29 | Moderna | No |
| 5 | 2022-09-10 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Within 15 minutes of second dose today, arm began itching and there was noticeable discoloration approximately two inches to left and below injection site.
Healthcare visit (other): EMT was at drive through vaccination site. She observed arm, listened to chest with stethoscope, no elevated heart rate noted and lungs clear, and asked if I had ever had an allergic reaction before. No need for further medical treatment. Itching preceded dark discoloration of upper arm.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): I did not sign up for vsafe after my initial dose. 10 days following initial dose, I had redness, itching and pain at injection site that resolved within approximately 2 days. Just wanted you to have that information for your records.
Release 11 — day 0, dose 4
Systemic reaction (other): None so far - received fourth vaccination at about 10:30 am today
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | ✓ | ✓ | ✓ |
| HCVO | Pruritus | ✓ | ✓ | ✓ |
| HCVO | Skin discolouration | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Injection site discolouration | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release